Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: The state Supreme Judicial Court said in an order released Friday that Monday’s planned court hearing in an appeal brought by the Vapor Technology Association will be postponed until further notice. The court is awaiting the results of new vaping regulations the state plans to issue next week before making a decision on the case. Republican Gov. Charlie Baker last week signed into law new restrictions on flavored tobacco and vaping products and promised to rescind the state’s emergency ban of the sale of all vaping products. Baker said the state’s Public Health Council will meet Wednesday to adopt new regulations as part of the new state law, at which point he’ll lift the emergency ban. The ban was imposed in September and set to last until the end of December. Neighboring Rhode Island also has a temporary ban on the sale of flavored vaping products. Democratic Gov. Gina Raimondo signed an executive order in September and the health department issued emergency regulations Oct. 4 to implement a four-month ban, with an optional two-month extension. Rhode Island lawmakers have said they’ll address vaping in the next legislative session, which begins in January. Democratic Gov. Ned Lamont of Connecticut is trying to figure out how to regulate vaping, after expressing an interest in banning flavored vaping products. A new law recently took effect in Connecticut that increased the age to 21 for someone to purchase vaping products. Claim: Massachusetts high court delays hearing on vaping ban suit.
[EX A]: Massachusetts’ highest court is holding off hearing arguments in the vaping industry’s challenge of the state’s temporary ban on vapor products.

[EX Q]: Paragraph: No mention of the cost of treatment. This is important if the surgery is not a permanent fix for acute sinusitis. Repeated operations and continued medications need to be compared to cost for traditional surgery. No quantitative estimate of the benefits of the new procedure. There was a study of 10 people that found “no safety concerns”, but readers should be told more about this very small group. What were the long term outcomes and did these patients eventually have to have further sinuplasty, more invasive surgery or continue to take medications to relieve sinusitits? The story mentions that a larger, randomized trial is underway to better understand the risks and benefits of sinuplasty compared to medication and traditional sinus surgery. Mentions that more information is needed and no one knows if balloon sinuplasty works as well as the more traditional surgical option for chronic sinusitis. Mentions that general anesthesia is still needed for balloon procedure and this comes with its own set of health risks. There isn’t much evidence for the story to report. The story did stress the importance of a randomized trial underway comparing medication, traditional sinus surgery and the newer balloon sinuplasty. Story describes this trial and the need for further evidence before this new procedure can be widely recommended. Mentions that this procedure should not have been FDA approved with so little quality evidence. No evidence of disease mongering. The story mentions that this procedure would be for chronic, not acute sinunitis and describes how these are different. Good balance of information on treatment options with input from otolaryngologists not affliated with the makers of the device who are able to provide perspective on the new procedure. They mention that further study is needed. There is a note that one of the physicans studying the new sinuplasty has no financial ties to Acclarent, maker of the balloon devices used in this type of sinuplasty. Mentions that this form of sinuplasty is not for everybody and that it may not prevent the need for more comprehensive surgery in which bone and tissue are removed. There is mention of other options including medication and the more traditional surgery, which is decribed as highly effective, but with a painful recovery and side effects such as scar tissue. Quantification of the incidence of this and other side effects of traditional surgery would be useful. The story is clear that the FDA approved the device but that it still needs to undergo further study via randomized controlled trials. Story mentions that this is a new procedure only offerred by 100 doctors. This story is a blananced presentation of sinuplasty and the information here does not appear to be from a press release. The are quotes from otolaryngologists not affliated with the makers of the device who are able to provide perspective on the new sinuplasty procedure. Claim: A balloon instead of a knife: Sinuplasty for ailing sinuses
[EX A]: This story provides a good balance of information on a new treatment option for chronic sinusitis, and there is corroboration with otolaryngologists not affiliated with the makers of the balloon device who are able to provide perspective on the procedure. The story clearly notes this procedure would be for chronic, not acute sinusitis and describes how these are different. The story explains that this form of sinuplasty is not for everybody, and that it may not prevent the need for more comprehensive surgery in which bone and inflamed tissue are removed to open the sinus passages. More information is needed on the safety and efficacy of balloon sinuplasty, and no one knows if this surgery works as well as traditional surgery for chronic sinusitis. The story mentions other options for treating chronic sinusitis, including medication and sinus surgery, which is described as highly effective, but with a painful recovery and side effects such as scar tissue. Quantification of the incidence of side effects with traditional surgery would be useful. While there is not much quantitative evidence available on the new procedure, the story stresses the importance of a randomized trial underway comparing medication, traditional sinus surgery and the newer balloon sinuplasty. There is adequate description of this trial and the need for further evidence before this new procedure can be widely recommended. There is a caveat that this procedure should not have been FDA approved with so little quality evidence: a study of 10 people that found “no safety concerns”, but readers should be told more about this very small group. What were the long term outcomes and did these patients eventually have to undergo further sinuplasty, more invasive surgery or continue to take medications to relieve their chronic sinusitis? The story explains that general anesthesia is still needed for the balloon procedure and this comes with its own set of health risks and additional costs. There is no mention of the cost of this newer procedure. This is important information if the surgery is not a permanent fix for chronic sinusitis. A cost comparison of the newer sinuplasty, which may require repeated operations, sinus medications and traditional surgery is needed.

[EX Q]: Paragraph: José Miguel Cisneros, director of the infectious disease department at Seville’s Virgen del Rocío Hospital, on Tuesday announced the first casualty since the outbreak was declared on Aug. 15. Authorities have closed the pork meat supplier’s plant and recalled all of its products. Cisneros said roughly half of the 114 people affected by the bacteria remain hospitalized. Health Minister María Luisa Carcedo said an investigation is looking into how the meat evaded what she called “strict food safety controls.” Listeria is a bacteria that usually causes mild illness in healthy people but can be dangerous to pregnant women and those with weakened immune systems. Claim: Woman dies in Spain as listeria-in-pork outbreak sickens 114.
[EX A]:
Health authorities in Spain are on high alert after a 90-year-old woman died amid a listeria outbreak in the southern region of Andalusia that has affected more than 110 people.